Patent · US Expired

Corticoid therapy

US6258802A · kind A · utility

1Cited by
0References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 6, 1999
Grant dateJul 10, 2001
Priority date
Expiry dateOct 6, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Treatments in which a progestational corticoid active compound is administered are improved by additionally administering a selective estrogen receptor modulator.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.